• AMPK, ULK1, and Autophagy Under Energy Stress

  2026-09-16

  The reference study revises the canonical view that AMPK generally activates autophagy during glucose starvation, showing instead that AMPK suppresses ULK1-driven autophagy initiation while protecting the autophagy machinery from caspase-mediated loss. Its findings support a context-dependent model in which AMPK limits energy-intensive autophagy during severe energy stress but preserves the capacity to restore cellular homeostasis.

• CD28–ARS2–PKM Splicing in CD8+ T Cells

  2026-09-15

  The reference study identifies a CD28–ARS2 signaling axis that reshapes alternative splicing in activated CD8+ T cells, favoring PKM2 over PKM1 and enabling flexible glucose metabolism. Its findings connect costimulatory signaling to interferon-γ production and antitumor function through a mechanism that is distinct from canonical CD28–PI3K activation.

• Carrier-Platin and the ROS Storm in Cancer Cells

  2026-09-15

  Liu et al. developed carrier-platin, a poly(amino acid)-based formulation containing ultrasmall platinum nanoparticles that rapidly elevates intracellular reactive oxygen species in cancer cells. The study links this ROS burst to cell death within approximately 30 minutes through a mechanism distinct from classical platinum-induced DNA damage, apoptosis, and ferroptosis.

• Tobramycin: Workflows for Bacterial Assays

  2026-09-14

  Build reproducible Tobramycin susceptibility, mechanism, and resistance experiments around broth microdilution, controlled inocula, and carefully interpreted MIC data. This guide translates historical clinical-isolate methods into practical workflows while separating evidence-backed benchmarks from modern assay recommendations.

• AMG 487: CXCR3 Assay Reliability Guide

  2026-09-14

  This scenario-based guide explains how AMG 487 (SKU B3266) can improve the interpretability of CXCR3 migration, calcium, viability, and macrophage-polarization experiments. It combines potency data, formulation guidance, metabolism considerations, and practical vendor-selection criteria for reproducible laboratory workflows.

• AMPK, ULK1, and Autophagy Under Energy Stress

  2026-09-13

  The reference study overturns the prevailing view that AMPK uniformly activates autophagy during energy shortage. Instead, it shows that AMPK suppresses ULK1-dependent autophagy initiation while protecting autophagy machinery from caspase-mediated degradation, thereby balancing immediate energy conservation with later recovery.

• NAD+ and AMPK: Reading Energy-Stress Signals

  2026-09-12

  Nicotinamide Adenine Dinucleotide (NAD+) is more than a redox cofactor: it helps frame how researchers interpret energy-stress experiments. This article connects NAD+ chemistry with the revised AMPK–ULK1 model and provides practical guidance for designing better metabolic and autophagy assays.

• Risedronate Sodium: Practical FPPS Workflows

  2026-09-11

  Build more reproducible Risedronate Sodium assays for osteoclast biology, tumor-cell viability, and pulmonary delivery research. This guide combines solvent-aware preparation, dose-response design, orthogonal readouts, and formulation troubleshooting for translational experiments.

• Doxorubicin as a Probe of Persister Ferroptosis

  2026-09-11

  Doxorubicin is more than a conventional cancer chemotherapy drug: it can serve as a controlled selective pressure for studying drug-tolerant persister states. This article connects Adriamycin-mediated DNA damage with lipidomic and mitochondrial features that may expose persister cells to ferroptosis.

• 1-myristoylglycerophosphocholine Research Guide

  2026-09-10

  1-myristoylglycerophosphocholine, also called 14:0 Lyso-PC, is a phosphocholine lysophospholipid for studying lipid-mediated cellular responses. Product data support its use in smooth muscle and signaling assays, while peer-reviewed evidence shows that LysoPC accumulation can promote fibroblast activation in experimental pulmonary fibrosis.

• Fenipentol (1-Phenyl-1-pentanol) Research Guide

  2026-09-10

  Fenipentol, also called 1-Phenyl-1-pentanol, is a small molecule associated with Ligusticum chuanxiong cortex chemistry and estrogen receptor α docking. Its historical secretion data support use as a research probe for choleretic, pancreatic, and gastrointestinal physiology studies, not as evidence of current clinical efficacy.

• Baicalin Methyl Ester: Intestinal Barrier Workflow

  2026-09-09

  Baicalin methyl ester provides a practical, pathway-oriented tool for studying LPS-induced intestinal barrier damage in MODE-K cells and mouse models. Its value lies in pairing cytokine suppression with MLCK/ZO-1 and tight-junction readouts, enabling stronger mechanism-to-phenotype validation than a single inflammatory marker.

• (Z)-4-Hydroxytamoxifen: Assay Design by Mechanism

  2026-09-09

  Explore (Z)-4-Hydroxytamoxifen as a high-affinity ER probe through a mechanism-first assay framework. This article connects estrogen receptor modulation with lessons from targeted nanoparticle research while clearly separating validated biology from experimental extrapolation.

• Obacunone, Akt/p53, and Ferroptosis in Ovarian Cancer

  2026-09-08

  A 2025 study identifies obacunone as a potential inducer of ferroptosis in ovarian cancer by linking reduced Akt phosphorylation with increased p53 signaling, impaired antioxidant defense, and lipid peroxidation. Its use of Fer-1 and the Akt activator SC 79 provides a pharmacological framework for testing pathway involvement, while the cell and xenograft results support further investigation rather than clinical conclusions.

• Gemini QACs: Broad-Spectrum Biocidal Design

  2026-09-08

  The reference study synthesizes 16 octenidine-inspired gemini quaternary ammonium compounds and identifies derivatives with improved combinations of antibacterial, antifungal, virucidal, solubility, and cytotoxicity profiles. Its structure–activity analysis shows how cationic architecture and polarity can be tuned to address limitations of established disinfectants while retaining broad membrane-active biocidal behavior.

8540 records 7/570 page Previous Next First page 上5页 678910 下5页 Last page